Does Coffee Help Fatty Liver? The Evidence on MASLD, MASH, and GLP-1s
Coffee may reduce liver fibrosis risk by up to 40%. This guide covers the NAFLD-to-MASLD rename, diet reversal, GLP-1 therapy, and non-invasive fibrosis testing.
Coffee may reduce liver fibrosis risk by up to 40%. This guide covers the NAFLD-to-MASLD rename, diet reversal, GLP-1 therapy, and non-invasive fibrosis testing.
Over 1,000 drugs and supplements can cause liver toxicity. Learn the ALT and bilirubin thresholds doctors use to diagnose DILI and what to do next.
People with type 2 diabetes have a substantially higher rate of MASLD and a faster path to liver fibrosis than the general population. This article covers the mechanisms, screening tools, and evidence-based treatment options, with clear notes on what is established versus what still needs confirmation.
MASLD (metabolic dysfunction-associated steatotic liver disease) is common in people with obesity. This article explains the mechanism, risk by subgroup, and where treatment evidence is strong versus still emerging.
Obeticholic acid causes pruritus in up to 70% of patients. Learn the mechanism, severity grading, management strategies, and how it compares to resmetirom and pioglitazone side effects in MASLD treatment.
Postmenopausal women face a sharp rise in MASLD risk after estrogen loss. Learn how menopause, diabetes, obesity, and lean MASLD interact, plus current treatment options backed by clinical evidence.
A guide to vitamins, supplements, and evidence-based strategies for managing crested wheatgrass allergy symptoms, including quercetin, vitamin C, vitamin D, butterbur, and more.
A guide to managing crested wheatgrass pollen allergies using evidence-based natural remedies, sublingual immunotherapy, antihistamines, and lifestyle strategies. Includes dosing, trial data, and practical protocols.
What is actually established about Blue Cross Blue Shield's coverage of metformin, what varies by regional plan and year, and how to verify your own cost before you fill a prescription.
A detailed guide to BCBS Michigan metformin coverage, tier placement, out-of-pocket costs, prior authorization rules, and how to reduce what you pay at the pharmacy.
Metformin causes modest weight loss in some patients but is not approved as a weight-loss drug. Learn what the clinical evidence says about metformin and body weight, who benefits most, and how it compares to dedicated obesity medications.
A breakdown of metformin's long-term safety record, covering kidney function, B12 depletion, cancer risk, cardiovascular effects, and the TAME longevity trial, with specific numbers, named studies, and clinical guidance.
A detailed guide to Affinity Health Plan metformin coverage, tier placement, prior authorization rules, and how to minimize your out-of-pocket cost for this first-line diabetes and longevity drug.
A detailed guide to Centene Corporation's metformin coverage across Medicaid, Medicare Advantage, and Marketplace plans, including formulary tiers, prior authorization rules, and cost-saving strategies.
A detailed clinical guide on Molina Healthcare's metformin coverage, formulary tiers, cost-sharing rules, prior authorization requirements, and how to get metformin for as little as $0 through Molina's plans.
A detailed breakdown of Network Health insurance coverage for metformin, including formulary tiers, prior authorization requirements, cost-saving strategies, and what to do if coverage is denied.
A complete guide to Quartz Health Solutions metformin coverage, including formulary tiers, prior authorization rules, out-of-pocket costs, and what to do if coverage is denied.
A detailed guide to Tufts Health Plan metformin coverage, including formulary tiers, prior authorization requirements, cost-sharing estimates, and how to minimize out-of-pocket costs for this widely prescribed diabetes and longevity drug.
A breakdown of senolytics, rapamycin, metformin, and biological age testing for longevity, what the current trial data actually supports and what remains experimental.
A guide to mild cognitive decline covering biological aging, cellular senescence, mitochondrial dysfunction, and frailty syndrome, with evidence-based interventions and dosing details.
A clinical deep-dive into rapamycin, senolytics, metformin, and biological age testing for longevity. Evidence-based guidance on what works, what is experimental, and what healthy adults should know before taking any longevity drug.
A guide to frailty syndrome covering the Fried phenotype criteria, biological mechanisms including sarcopenia and mitochondrial dysfunction, and interventions supported by randomized trial data.
A deep dive into GLP-1 receptor agonists and four companion longevity drugs used off-label: rapamycin, metformin, nicotinamide riboside, and NMN. Covers mechanisms, trial data, doses, and candidacy criteria.
A deep dive into glucosamine as a longevity compound, plus the most current evidence on rapamycin, metformin, nicotinamide riboside, and NMN for healthy aging.
Inflammaging is the chronic, low-grade inflammatory state that accelerates biological aging, drives cellular senescence, and raises the risk of cardiovascular disease, dementia, and frailty. Learn what the science says and what you can do about it.
A breakdown of metformin, rapamycin, NR, NMN, and glucosamine as off-label longevity agents. Covers mechanisms, the state of trial evidence, dosing ranges used in practice, risks, and how to talk to your doctor.
A deep-dive into nicotinamide riboside (NR): how it raises NAD+, what human trials show, how it compares to NMN, rapamycin, metformin, and glucosamine, and what doses are supported by current evidence.
A guide to off-label metformin dosing for longevity, covering evidence from TAME, ITP mouse data, rapamycin weekly protocols, and NMN/NR NAD+ precursor dosing, with inline citations to primary sources.
A clinical deep-dive into rapamycin side effects, safety signals from senolytic and longevity trials, long-term metformin safety comparisons, and the lab monitoring schedule every off-label user needs.
Keine Senolytika haben Phase-3-Studien bestanden. Alle zeigten Nebenwirkungen, von Thrombozytopenie bis Magen-Darm-Beschwerden. Die Evidenzlage im Detail.
A breakdown of whether healthy adults should use rapamycin for longevity, covering human trial data, dosing protocols, side-effect profiles, biological age testing, senolytics, and metformin as comparators.
Spermidine triggers autophagy, reduces cardiovascular risk, and may extend healthspan. Learn the evidence-backed doses, food sources, and how it compares to rapamycin, metformin, NR, and NMN.
If a parent or sibling had dementia, your risk is real but not fixed. This clinically reviewed guide covers genetic risk, the critical hormone timing window, lifestyle evidence, and actionable steps for adults over 50 with a family history of dementia.
Biological age reflects how well your cells, organs, and epigenome are functioning, not how long you have been alive. Learn which tests measure it accurately, what the evidence says about slowing it, and which longevity drugs are ready for clinical use.
A guide to the blood tests, epigenetic clocks, and organ-function panels that measure biological age, plus what is and is not established about rapamycin, metformin, and senolytics as interventions on those numbers.
A clinical deep-dive into losartan's documented effects on hair and skin, including alopecia, psoriasiform reactions, and rare dermatologic adverse events, with primary-literature citations and prescriber guidance.
A guide to obtaining a low-dose naltrexone (LDN) prescription in Virginia, covering telehealth options, compounding pharmacy requirements, labs, dosing, and insurance coverage.
A guide to switching low-dose naltrexone (LDN) from or to other opioid-antagonist and opioid-agonist medications, covering mechanism, timing risk, washout windows, and compounding considerations, with an emphasis on where evidence is solid and where it is not.
Your first month of low-dose naltrexone: weekly symptom tracking, sleep and side effects, prescription checks and the month-one treatment review.
A guide to how low-dose naltrexone (LDN) affects liver enzymes and hepatic safety, covering clinical trial data, FDA labeling, monitoring protocols, and who should avoid LDN entirely.
How low-dose naltrexone (LDN) may support muscle preservation through glial modulation, cytokine reduction, and IGF-1 pathway effects. MD/PharmD-level review with primary literature, dosing guidance, and a decision framework.
A clinician-level guide to safely restarting compounded low-dose naltrexone (LDN) after an acute illness, including when to pause, how to re-titrate, and what the evidence says about opioid receptor modulation and immune function.
How long before surgery should you stop low-dose naltrexone? This MD/PharmD-level guide covers the evidence-based hold window, opioid-antagonism pharmacokinetics, anesthesia risks, and restart timing after your procedure.
Does stopping low-dose naltrexone cause rebound pain, inflammation, or withdrawal? A deep dive into the pharmacology, trial data, and tapering protocols for LDN discontinuation.
A clinician-level guide to adjusting low-dose naltrexone (LDN) dosing, timing, and monitoring across seasons, covering winter immune shifts, summer heat effects, and condition-specific seasonal flare patterns.
A guide to adjusting compounded low-dose naltrexone (LDN) dosing times during air travel, crossing multiple time zones, and managing circadian disruption without losing therapeutic benefit.
A guide to bremelanotide (PT-141) covering its melanocortin mechanism, FDA-approved dosing, side effects, and a head-to-head comparison with PDE5 inhibitors sildenafil, tadalafil, vardenafil, and avanafil for erectile dysfunction.
How fast do PDE5 inhibitors work? Compare onset times, peak effect windows, and duration for sildenafil, tadalafil, vardenafil, and avanafil. Includes daily vs. on-demand tadalafil dosing, Trimix injection protocols, and PT-141 dosing for ED.
A guide to every common and serious side effect of PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil), including NAION, priapism, and Trimix injection complications, with dosing thresholds and emergency management steps.
A guide to penile implants covering inflatable and malleable devices, surgical outcomes, satisfaction rates, and how implants compare to sildenafil, tadalafil, vardenafil, and avanafil.
A guide to pentoxifylline for Peyronie's disease covering mechanism, dosing, the strength of clinical evidence, combination therapy with PDE5 inhibitors, and when to consider escalation to injection or surgery.
A guide to Peyronie's disease covering penile curvature causes, scar tissue formation, diagnosis criteria, collagenase injections, surgery, and how the condition intersects with erectile dysfunction and low libido.
A guide to premature ejaculation covering DSM-5 criteria, IELT thresholds, dapoxetine, SSRIs, topical agents, behavioral techniques, and when PE overlaps with ED, low libido, or Peyronie's disease.
A guide to priapism emergency management covering time-to-treatment windows, aspiration and phenylephrine protocols, PDE5 inhibitor side effects, Trimix injection complications, and NAION risk.
A complete clinical guide to priapism covering ischemic vs. nonischemic types, emergency aspiration, intracavernosal phenylephrine, surgical shunting, and how priapism relates to erectile dysfunction, testosterone, and GLP-1 medications.
A detailed clinical comparison of PT-141 (bremelanotide) vs PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) covering mechanism, dosing, efficacy data, side effects, and how to choose.
A comparison of tadalafil 2.5 to 5 mg daily dosing versus 10 to 20 mg on-demand dosing for erectile dysfunction, including onset times, PDE5 inhibitor comparisons, Trimix protocols, and PT-141 dosing guidance.
A guide to topical lidocaine for premature ejaculation, covering evidence from randomized trials, correct application technique, dosing, side effects, and how it compares with PDE5 inhibitors like sildenafil, tadalafil, vardenafil, and avanafil.
A guide to yohimbine for ED, including how it compares to sildenafil, tadalafil, vardenafil, and avanafil, with dosing, side effects, and evidence from named trials.
Testosterone replacement therapy can trigger or worsen acne in some men. Learn why it happens, which treatments work, and how to manage it without stopping TRT.